In an undelivered consistory address, the prefect for the Dicastery for Divine Worship and the Discipline of the Sacraments ...

MediLink Therapeutics has signed an exclusive licensing agreement with Roche for the development and commercialisation of ...

If you are wondering whether Roche Holding is still an attractive opportunity after its recent run, or whether that value is already reflected in the price, this article will walk through what the ...

Roche has received a dressing-down for omitting important safety information from a cancer drug dosing webpage. A U.K. self-regulatory body concluded Roche brought discredit upon, and reduced ...

Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in its ...

Think Roche is out of the Alzheimer’s disease business? Think again. Just over a week after handing back rights to two failed assets to AC Immune, Roche Pharmaceuticals CEO Teresa Graham turned ...

Roche has removed eight phase 1 and 2 oncology and neurology candidates from its pipeline as part of a set of “trade-offs” intended to “increase the overall portfolio value and speed up development.” ...

Roche targets liver disease treatments with acquisition Deal includes $14.50 a share, potential milestone payments up to $6.00 a share Roche flags potential to treat obesity-related conditions The ...

BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...

Swiss pharmaceuticals company Roche agreed to acquire U.S.-based weight-loss drugmaker Carmot Therapeutics, which develops anti-obesity and diabetes drugs, for $2.7 billion, according to a press ...